{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:22:21Z","timestamp":1790677341007,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0548-2","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T06:38:47Z","timestamp":1520231927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum"],"prefix":"10.1186","volume":"19","author":[{"given":"Mar\u00eda","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Garc\u00eda-Oguiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Garc\u00eda-Cobaleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixto","family":"Garc\u00eda-Mi\u00f1aur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Santos-Simarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-4891","authenticated-orcid":false,"given":"Elena","family":"Dom\u00ednguez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"548_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/sj.ejhg.5201594","volume":"14","author":"RC Hennekam","year":"2006","unstructured":"Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet. 2006;14:981\u20135.","journal-title":"Eur J Hum Genet"},{"key":"548_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/jmg.2006.046698","volume":"44","author":"D Bartholdi","year":"2007","unstructured":"Bartholdi D, Roelfsema JH, Papadia F, Breuning MH, Niedrist D, Hennekam RC, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300. J Med Genet. 2007;44:327\u201333.","journal-title":"J Med Genet"},{"key":"548_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajmg.a.33153","volume":"152A","author":"O Bartsch","year":"2010","unstructured":"Bartsch O, Labont\u00e9 J, Albrecht B, Wieczorek D, Lechno S, Zechner U, et al. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome. Am J Med Genet. 2010;152A:181\u20134.","journal-title":"Am J Med Genet"},{"key":"548_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12881-016-0361-8","volume":"17","author":"M L\u00f3pez","year":"2016","unstructured":"L\u00f3pez M, Seidel V, Santiba\u00f1ez P, Cervera-Acedo C, Castro-de CP, Dominguez-Garrido E. First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant. BMC Med Genet. 2016;17:97.","journal-title":"BMC Med Genet"},{"issue":"6538","key":"548_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/376348a0","volume":"376","author":"F Petrij","year":"1995","unstructured":"Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995;376(6538):348\u201351.","journal-title":"Nature"},{"key":"548_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1086\/429130","volume":"76","author":"JH Roelfsema","year":"2005","unstructured":"Roelfsema JH, White SJ, Ariy\u00fcrek Y, Bartholdi D, Niedrist D, Papadia F, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005;76:572\u201380.","journal-title":"Am J Hum Genet"},{"key":"548_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cge.12348","volume":"87","author":"G Negri","year":"2015","unstructured":"Negri G, Milani D, Colapietro P, Forzano F, Della MM, Rusconi D, et al. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Clin Genet. 2015;87:148\u201354.","journal-title":"Clin Genet"},{"key":"548_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-genom-090613-094245","volume":"15","author":"JA Fahrner","year":"2014","unstructured":"Fahrner JA, Bjornsson HT. Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states. Annu Rev Genomics Hum Genet. 2014;15:269\u201393.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"548_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0035-1564571","volume":"4","author":"S Spena","year":"2015","unstructured":"Spena S, Gervasini C, Milani D. Ultra-rare syndromes: the example of Rubinstein-Taybi syndrome. J Pediatr Genet. 2015;4:177\u201386.","journal-title":"J Pediatr Genet"},{"key":"548_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MCD.0000000000000143","volume":"25","author":"MJ Hamilton","year":"2016","unstructured":"Hamilton MJ, Newbury-Ecob R, Holder-Espinasse M, Yau S, Lillis S, Hurst JA, et al. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum. Clin Dysmorphol. 2016;25:135\u201345.","journal-title":"Clin Dysmorphol"},{"key":"548_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/humu.22922","volume":"37","author":"G Negri","year":"2016","unstructured":"Negri G, Magini P, Milani D, Colapietro P, Rusconi D, Scarano E, et al. From whole gene deletion to point mutations of EP300-positive Rubinstein-Taybi patients: new insights into the mutational Spectrum and peculiar clinical hallmarks. Hum Mutat. 2016;37:175\u201383.","journal-title":"Hum Mutat"},{"key":"548_CR12","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/ajmg.a.36883","volume":"167A","author":"BD Solomon","year":"2015","unstructured":"Solomon BD, Bodian DL, Khromykh A, Mora GG, Lanpher BC, Iyer RK, et al. Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome. Am J Med Genet A. 2015;167A:1111\u20136.","journal-title":"Am J Med Genet A"},{"key":"548_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ccr3.598","volume":"4","author":"EA Sellars","year":"2016","unstructured":"Sellars EA, Sullivan BR, Schaefer GB. Whole exome sequencing reveals EP300 mutation in mildly affected female: expansion of the spectrum. Clin Case Rep. 2016;4:696\u20138.","journal-title":"Clin Case Rep"},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1002\/ajmg.a.37940","volume":"170","author":"P Fergelot","year":"2016","unstructured":"Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour CM, Arveiler B, et al. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Am J Med Genet A. 2016;170:3069\u201382.","journal-title":"Am J Med Genet A"},{"key":"548_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.ejhg.5201791","volume":"15","author":"N Zimmermann","year":"2007","unstructured":"Zimmermann N, Acosta AM, Kohlhase J, Bartsch O. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome. Eur J Hum Genet. 2007;15:837\u201342.","journal-title":"Eur J Hum Genet"},{"key":"548_CR16","doi-asserted-by":"publisher","unstructured":"Jagla M, Tomasik TB, Czyz O, Krol M, van Houdt JK, Kwinta P, et al. Rubinstein-Taybi because of a novel EP300 mutation with novel clinical findings. Clin Dysmorphol. 2016; \n                    https:\/\/doi.org\/10.1097\/MCD.0000000000000164\n                    \n                  .","DOI":"10.1097\/MCD.0000000000000164"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T19:34:17Z","timestamp":1551728057000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0548-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0548-2","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"17 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work has been approved by the Committee for Ethics in Clinical Research in La Rioja (CEICLAR). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study or from their parents in the case of minors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent Form for Publication of personal information in a scientific journal, including clinical data and image and photographs was obtained from all individual participants included in the study or from their parents in the case of minors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}